EANS-News: Epigenomics AG Presents Clinical Data from Prostate Cancer Prognosis Study at ASCO
Biomarker mPITX2 for prostate cancer prognostic application successfully validated First clinical laboratory in Germany to start offering mPITX2 testing service Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. new product/research/Molecular diagnostics Press release, Berlin, Germany ...